|
Volumn 7, Issue 3-4, 2003, Pages 153-157
|
Low dose methotrexate and vinblastine, given weekly to patients with desmoid tumours, is associated with major toxicity
|
Author keywords
Desmoids; Methotrexate; Sarcomas; Vinblastine
|
Indexed keywords
CORTICOSTEROID;
MELPHALAN;
METHOTREXATE;
METOCLOPRAMIDE;
ONDANSETRON;
TUMOR NECROSIS FACTOR;
VINBLASTINE;
ADOLESCENT;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DESMOID TUMOR;
DIARRHEA;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
FATIGUE;
FEMALE;
HEADACHE;
HEPATITIS;
HUMAN;
INTERSTITIAL PNEUMONIA;
LEUKOPENIA;
LIVER TOXICITY;
LOW DRUG DOSE;
MALE;
NAUSEA;
PERFORMANCE;
POLYNEUROPATHY;
PRIORITY JOURNAL;
SCORING SYSTEM;
SIDE EFFECT;
TREATMENT OUTCOME;
|
EID: 0346495975
PISSN: 1357714X
EISSN: None
Source Type: Journal
DOI: 10.1080/13577140310001644779 Document Type: Article |
Times cited : (15)
|
References (8)
|